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Introduction
Phthalates are chemical additives incorporated in PVC-
based materials to make them more pliable. Intensive care
management, especially in the pediatric setting, relies
heavily on the use of soft and flexible indwelling medical
devices. As phthalates are not chemically bound to these
devices, they can leach during use [1,2]. Environmental
phthalate exposure has been associated with attention def-
icit disorders in children [3,4].
Objectives
We hypothesized that in children treated in the pediatric
intensive care unit (PICU), phthalates leaching from the
indwelling medical devices contribute to the important
long-term attention deficit.
Methods
Plasma concentrations of di(2-ethylhexyl)phthalate (DEHP)
metabolites were quantified in 100 healthy children and in
449 children who had been treated in PICU and were neu-
rocognitively tested 4 years later. In a development patient
cohort (N = 228), a multivariable bootstrap study identified
the stable thresholds of the exposure to DEHP metabolites
that appeared toxic for neurocognitive development.
Subsequently, in a second patient cohort (N = 221), the
observed independent associations were validated.
Results
Mean plasma concentrations of the DEHP metabolites
were 45- to 280-times higher than normal upon PICU
admission, decreased rapidly but remained 3- to 29-
times elevated until PICU discharge (all P < 0.001).
After adjusting for baseline risk factors and for duration
of PICU stay, and further for complications occurring
during PICU stay, exceeding the toxic threshold for
exposure to the total DEHP metabolites was indepen-
dently associated with the attention deficit (all P≤0.01)
and with the impaired motor coordination (all P≤0.04).
The association between phthalate exposure and the
attention deficit was confirmed in the validation cohort
(all P≤0.01). The size of these effects was the equivalent
of 34%-68% of the differences between patients and
controls.
Conclusions
Iatrogenic exposure to DEHP metabolites during inten-
sive care was independently and robustly associated with
the important attention deficit observed in children
4 years after pediatric critical illness.
Trial registration at ClinicalTrials.gov: NCT00214916
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